ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Dose optimization of intrathecal administration of human umbilical cord mesenchymal stem cells for the treatment of subacute incomplete spinal cord injury

Cao, Ting-Ting; Chen, Huan; Pang, Mao; Xu, Si-Si; Wen, Hui-Quan; Liu, Bin*; Rong, Li-Min*; Li, Mang-Mang*南方医科大学; 中山大学; i
Neural Regeneration Research2022-8DOI: 10.4103/1673-5374.332151
6被引6阅读
引用收藏
分享

摘要

Human umbilical cord mesenchymal stem cells (hUC-MSCs) are a promising candidate for spinal cord injury (SCI) repair owing to their advantages of low immunogenicity and easy accessibility over other MSC sources. However, modest clinical efficacy hampered the progression of these cells to clinical translation. This discrepancy may be due to many variables, such as cell source, timing of implantation, route of administration, and relevant efficacious cell dose, which are critical factors that affect the efficacy of treatment of patients with SCI. Previously, we have evaluated the safety and efficacy of 4 x 10(6) hUC-MSCs/kg in the treatment of subacute SCI by intrathecal implantation in rat models. To search for a more accurate dose range for clinical translation, we compared the effects of three different doses of hUC-MSCs - low (0.25 x 10(6) cells/kg), medium (1 x 10(6) cells/kg) and high (4 x 10(6) cells/kg) - on subacute SCI repair through an elaborate combination of behavioral analyses, anatomical analyses, magnetic resonance imaging-diffusion tensor imaging (MRI-DTI), biotinylated dextran amine (BDA) tracing, electrophysiology, and quantification of mRNA levels of ion channels and neurotransmitter receptors. Our study demonstrated that the medium dose, but not the low dose, is as efficient as the high dose in producing the desired therapeutic outcomes. Furthermore, partial restoration of the gamma-aminobutyric acid type A (GABA(A)) receptor expression by the effective doses indicates that GABA(A) receptors are possible candidates for therapeutic targeting of dormant relay pathways in injured spinal cord. Overall, this study revealed that intrathecal implantation of 1 x 10(6) hUC-MSCs/kg is an alternative approach for treating subacute SCI.

学科与关键词

关键词
effective dosehuman umbilical cord mesenchymal stem cellsintrathecal implantationion channels neurotransmitterreceptorsspinal cord injurysubacute spinal cord injury.-aminobutyric acid type A (GABAA) receptors
相关
加载中…
  • hUC-MSC-mediated recovery of subacute spinal cord injury through enhancing the pivotal subunits β3 and γ2 of the GABAA receptor
    Cao, Tingting; Chen, Huan; Huang, Weiping; Xu, Sisi; Liu, Peilin; Zou, Weiwei; Pang, Mao; Xu, Ying; Bai, Xiaochun; Liu, Bin; Rong, Limin; Cui, Zhong-Kai*; Li, Mangmang*2022, 12(7): 3057-3078.被引 17
  • Clinical observation of umbilical cord mesenchymal stem cell transplantation in treatment for sequelae of thoracolumbar spinal cord injury
    Cheng Hongbin; Liu Xuebin; Hua Rongrong; Dai Guanghui; Wang Xiaodong; Gao Jianhua; An Yihua*Journal of Translational Medicine, 2014, 12: 253.被引 1
  • Multimodal Repair of Spinal Cord Injury With Mesenchymal Stem Cells
    Ma, Yuan-huan; Liang, Qing-yue; Ding, Ying; Han, Inbo; Zeng, Xiang*Neurospine, 2022, 19(3): 616-629.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Neural Regeneration Research
发表日期
2022-08
卷期
第 17 卷, 第 8 期
页码
1785-1794
DOI
10.4103/1673-5374.332151
语言
ENGLISH
期刊收录
CSCD-C.CAST-E
期刊等级
2区
成果收录
SCIE
资助标注
National Key Research and Development Program of China [2017YFA0105401]; National Natural Science Foundation of China [31671420, 81602482]; Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases

作者

  • C

    Cao, Ting-Ting (第一作者)

    southern med univ

  • C

    Chen, Huan

    southern med univ

查看全部 8 位作者收起作者
  • P

    Pang, Mao

    sun yat sen univ · i

  • X

    Xu, Si-Si

    southern med univ

  • W

    Wen, Hui-Quan

    sun yat sen univ

  • L

    Liu, Bin (通讯)

    sun yat sen univ · i

  • R

    Rong, Li-Min (通讯)

    sun yat sen univ · i

  • L

    Li, Mang-Mang (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417